FR

F. Anthony Romero

Genentech: 17 patents #143 of 2,392Top 6%
CP Constellation Pharmaceuticals: 12 patents #10 of 60Top 20%
TP Terns Pharmaceuticals: 7 patents #1 of 9Top 15%
Merck: 5 patents #2,116 of 9,382Top 25%
TE Terns: 4 patents #1 of 6Top 20%
MT Metabasis Therapeutics: 3 patents #25 of 71Top 40%
OP Oric Pharmaceuticals: 2 patents #21 of 33Top 65%
UB Unity Biotechnology: 2 patents #28 of 35Top 80%
Overall (All Time): #87,994 of 4,157,543Top 3%
37
Patents All Time

Issued Patents All Time

Showing 25 most recent of 37 patents

Patent #TitleCo-InventorsDate
12398127 Thyroid hormone receptor beta agonist compounds Thorsten A. Kirschberg, Randall L. Halcomb, Yingzi XU 2025-08-26
12378236 Compounds as GLP-1R agonists Corey REEVES, Christopher T. JONES, Martijn Fenaux 2025-08-05
12378237 Compounds as GLP-1R agonists Corey REEVES, Christopher T. JONES, Martijn Fenaux 2025-08-05
12378238 Compounds as GLP-1R agonists Corey REEVES, Christopher T. JONES, Martijn Fenaux 2025-08-05
12378239 Compounds as GLP-1R agonists Corey REEVES, Christopher T. JONES, Martijn Fenaux 2025-08-05
12312339 Polo like kinase 4 inhibitors Chudi Ndubaku, Jared MOORE, Paul Gibbons, Jae Hyuk CHANG, Xiaohui Du +11 more 2025-05-27
12247032 Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases Mark Edward Zak, Naomi Rajapaksa, Yun-Xing Cheng, Jessica Grandner, Daniel Shore +1 more 2025-03-11
12240835 Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity Thorsten A. Kirschberg, Randall L. Halcomb, Yingzi XU 2025-03-04
12024507 Compounds as GLP-1R agonists Corey REEVES, Christopher T. JONES, Martijn Fenaux, Gary W. Luehr 2024-07-02
11858915 Polo like kinase 4 inhibitors Chudi Ndubaku, Jared MOORE, Paul Gibbons, Jae Hyuk CHANG, Xiaohui Du +11 more 2024-01-02
11731943 Therapeutic compounds, compositions and methods of use thereof James John Crawford, Mark Edward Zak, Terry Kellar, Yun-Xing Cheng, Wei Li +4 more 2023-08-22
11649241 Pyrazolochlorophenyl compounds, compositions and methods of use thereof Mark Edward Zak, Po-Wai Yuen, Emily Hanan 2023-05-16
11247989 Therapeutic compounds and uses thereof Patrick Cyr, Sarah Bronner, Steven R. Magnuson, Vickie Hsiao-Wei Tsui, Jeremy M. Murray +4 more 2022-02-15
11203587 Thyroid hormone receptor beta agonist compounds Thorsten A. Kirschberg, Randall L. Halcomb, Yingzi XU 2021-12-21
11168070 Therapeutic compounds and uses thereof Patrick Cyr, Sarah Bronner, Steven R. Magnuson, Vickie Hsiao-Wei Tsui, John S. Wai +2 more 2021-11-09
11155557 Pyrazolopyrimidine compounds and methods of use thereof Mark Edward Zak, Guiling Zhao, Paul Gibbons, Wei Li, Yun-Xing Cheng +2 more 2021-10-26
10919911 Tricyclic ASK1 inhibitors Yingzi XU, Randall L. Halcomb, Thorsten A. Kirschberg 2021-02-16
10889571 Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias Thorsten A. Kirschberg, Randall L. Halcomb, Yingzi XU 2021-01-12
10800767 Thyroid hormone receptor beta agonist compounds Thorsten A. Kirschberg, Randall L. Halcomb, Yingzi XU 2020-10-13
10696655 Therapeutic compounds and uses thereof Patrick Cyr, Sarah Bronner, Steven R. Magnuson, Vickie Hsiao-Wei Tsui, John S. Wai +2 more 2020-06-30
10689416 Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer Ryan Hudson, Anne-Marie Beausoleil, Remi-Martin Laberge 2020-06-23
10519197 Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer Ryan Hudson, Anne-Marie Beausoleil, Remi-Martin Laberge 2019-12-31
10358437 Therapeutic compounds and uses thereof Brian K. Albrecht, Alexandre Cote, Terry Crawford, Martin Duplessis, Andrew C. Good +5 more 2019-07-23
10308614 Therapeutic compounds and uses thereof Brian K. Albrecht, Alexandre Cote, Terry Crawford, Martin Duplessis, Andrew C. Good +5 more 2019-06-04
10307426 Therapeutic compounds and compositions, and methods of use thereof Mark Edward Zak, Yun-Xing Cheng 2019-06-04